English  |  正體中文  |  简体中文  |  2818311  
???header.visitor??? :  28020573    ???header.onlineuser??? :  532
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"hung h w"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-25 of 45  (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2022-09-07T06:50:29Z Genotypic resistance in Helicobacter pylori strains correlates with susceptibility test and treatment outcomes after levofloxacinand clarithromycin-based therapies Liou J.-M.; Chang C.-Y.; Sheng W.-H.; Wang Y.-C.; Chen M.-J.; YI-CHIA LEE; Hung H.-W.; Chian H.; Chang S.-C.; Wu M.-S.; Lin J.-T.
臺大學術典藏 2022-09-07T06:50:01Z Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial Liou J.-M.; Bair M.-J.; Chen C.-C.; YI-CHIA LEE; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hung H.-W.; Lin J.-T.; Chang C.-Y.; Wu M.-S.
臺大學術典藏 2022-09-06T08:57:03Z Helicobacter pylori-seronegative gastric carcinoma: A subset of gastric carcinoma with distinct clinicopathologic features MING-SHIANG WU; Hung H.-W.; Wang J.-T.; Tseng C.-C.; Shun C.-T.; Wang H.-P.; Lee W.-J.; Lin J.-T.
臺大學術典藏 2022-09-06T07:43:19Z Genotypic resistance in Helicobacter pylori strains correlates with susceptibility test and treatment outcomes after levofloxacinand clarithromycin-based therapies Liou J.-M.; Chang C.-Y.; Sheng W.-H.; Wang Y.-C.; Chen M.-J.; Lee Y.-C.; Hung H.-W.; Chian H.; Chang S.-C.; MING-SHIANG WU; Lin J.-T.
臺大學術典藏 2022-02-18T08:46:52Z Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial Liou J.-M.; Bair M.-J.; CHIEN-CHUAN CHEN; Lee Y.-C.; Chen M.-J.; CHIEN-CHUAN CHEN; Tseng C.-H.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hung H.-W.; Lin J.-T.; Chang C.-Y.; Wu M.-S.
臺大學術典藏 2022-02-18T08:26:06Z Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial Liou J.-M.; Bair M.-J.; CHIEH-CHANG CHEN; Lee Y.-C.; Chen M.-J.; CHIEH-CHANG CHEN; Tseng C.-H.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hung H.-W.; Lin J.-T.; Chang C.-Y.; Wu M.-S.
臺大學術典藏 2022-02-18T08:26:05Z Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen–Negative Patients Hsu Y.-C.; Mo L.-R.; Chang C.-Y.; Wu M.-S.; Kao J.-H.; Wang W.-L.; Yang T.-H.; Wang C.-S.; Chiang M.-F.; CHIEH-CHANG CHEN; Fang Y.-J.; Hung H.-W.; Wu C.-Y.; Lin J.-T.
臺大學術典藏 2022-02-18T06:28:59Z Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial Liou J.-M.; Bair M.-J.; Chen C.-C.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; WEN-FENG HSU; Hung H.-W.; Lin J.-T.; Chang C.-Y.; Wu M.-S.
臺大學術典藏 2022-02-14T06:28:51Z Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial Liou J.-M.; Bair M.-J.; Chen C.-C.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; YU-JEN FANG; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hung H.-W.; Lin J.-T.; Chang C.-Y.; Wu M.-S.
臺大學術典藏 2022-02-14T06:28:50Z Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen–Negative Patients Hsu Y.-C.; Mo L.-R.; Chang C.-Y.; Wu M.-S.; Kao J.-H.; Wang W.-L.; Yang T.-H.; Wang C.-S.; Chiang M.-F.; Chen C.-C.; YU-JEN FANG; Hung H.-W.; Wu C.-Y.; Lin J.-T.
臺大學術典藏 2021-09-04T06:11:10Z Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen–Negative Patients Hsu Y.-C.; Mo L.-R.; Chang C.-Y.; Wu M.-S.; JIA-HORNG KAO; Wang W.-L.; Yang T.-H.; Wang C.-S.; Chiang M.-F.; Chen C.-C.; Fang Y.-J.; Hung H.-W.; Wu C.-Y.; Lin J.-T.
臺大學術典藏 2021-05-27T08:21:00Z Genotypic resistance in Helicobacter pylori strains correlates with susceptibility test and treatment outcomes after levofloxacinand clarithromycin-based therapies JYH-MING LIOU; Chang C.-Y.; Sheng W.-H.; Wang Y.-C.; Chen M.-J.; Lee Y.-C.; Hung H.-W.; Chian H.; Chang S.-C.; Wu M.-S.; Lin J.-T.
臺大學術典藏 2021-05-27T08:20:51Z Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial JYH-MING LIOU; Bair M.-J.; Chen C.-C.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hung H.-W.; Lin J.-T.; Chang C.-Y.; Wu M.-S.
臺大學術典藏 2021-03-18T02:03:40Z Helicobacter pylori-seronegative gastric carcinoma: A subset of gastric carcinoma with distinct clinicopathologic features Wu M.-S.; Hung H.-W.; Wang J.-T.; Tseng C.-C.; CHIA-TUNG SHUN; Wang H.-P.; Lee W.-J.; Lin J.-T.
臺大學術典藏 2021-03-18T02:02:38Z Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial Liou J.-M.; Bair M.-J.; Chen C.-C.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; CHIA-TUNG SHUN; Hsu W.-F.; Hung H.-W.; Lin J.-T.; Chang C.-Y.; Wu M.-S.
臺大學術典藏 2021-02-26T02:00:05Z Genotypic resistance in Helicobacter pylori strains correlates with susceptibility test and treatment outcomes after levofloxacinand clarithromycin-based therapies Liou J.-M.; Chang C.-Y.; WANG-HUEI SHENG; Wang Y.-C.; Chen M.-J.; Lee Y.-C.; Hung H.-W.; Chian H.; Chang S.-C.; Wu M.-S.; Lin J.-T.
臺大學術典藏 2021-02-18T08:38:06Z Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial Liou J.-M.; Bair M.-J.; Chieh-Chang Chen; Lee Y.-C.; Chen M.-J.; CHIEN-CHUAN CHEN; Tseng C.-H.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hung H.-W.; Lin J.-T.; Chang C.-Y.; Wu M.-S.
臺大學術典藏 2021-02-02T05:45:33Z Genotypic resistance in Helicobacter pylori strains correlates with susceptibility test and treatment outcomes after levofloxacinand clarithromycin-based therapies Liou J.-M.; Chang C.-Y.; Sheng W.-H.; Wang Y.-C.; Chen M.-J.; YI-CHIA LEE; Hung H.-W.; Chian H.; Chang S.-C.; Wu M.-S.; Lin J.-T.
臺大學術典藏 2021-02-02T05:45:19Z Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial Liou J.-M.;Bair M.-J.;Chen C.-C.;Yi-Chia Lee;Chen M.-J.;Chen C.-C.;Tseng C.-H.;Fang Y.-J.;Lee J.-Y.;Yang T.-H.;Luo J.-C.;Wu J.-Y.;Chang W.-H.;Chang C.-C.;Chen C.-Y.;Chen P.-Y.;Shun C.-T.;Hsu W.-F.;Hung H.-W.;Lin J.-T.;Chang C.-Y.;Wu M.-S.; Liou J.-M.; Bair M.-J.; Chen C.-C.; YI-CHIA LEE; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hung H.-W.; Lin J.-T.; Chang C.-Y.; Wu M.-S.
臺大學術典藏 2021-02-02T02:24:42Z Helicobacter pylori-seronegative gastric carcinoma: A subset of gastric carcinoma with distinct clinicopathologic features MING-SHIANG WU; Hung H.-W.; Wang J.-T.; Tseng C.-C.; Shun C.-T.; Wang H.-P.; Lee W.-J.; Lin J.-T.
臺大學術典藏 2021-02-02T02:21:46Z Genotypic resistance in Helicobacter pylori strains correlates with susceptibility test and treatment outcomes after levofloxacinand clarithromycin-based therapies Liou J.-M.; Chang C.-Y.; Sheng W.-H.; Wang Y.-C.; Chen M.-J.; Lee Y.-C.; Hung H.-W.; Chian H.; Chang S.-C.; MING-SHIANG WU; Lin J.-T.
臺大學術典藏 2021-02-02T02:21:14Z Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial Liou J.-M.; Bair M.-J.; Chen C.-C.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hung H.-W.; Lin J.-T.; Chang C.-Y.; MING-SHIANG WU
臺大學術典藏 2021-02-02T02:21:10Z Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen–Negative Patients Hsu Y.-C.; Mo L.-R.; Chang C.-Y.; MING-SHIANG WU; Kao J.-H.; Wang W.-L.; Yang T.-H.; Wang C.-S.; Chiang M.-F.; Chen C.-C.; Fang Y.-J.; Hung H.-W.; Wu C.-Y.; Lin J.-T.
臺大學術典藏 2021-01-15T03:52:49Z Helicobacter pylori-seronegative gastric carcinoma: A subset of gastric carcinoma with distinct clinicopathologic features Wu M.-S.; Hung H.-W.; Wang J.-T.; Tseng C.-C.; Shun C.-T.; HSIU-PO WANG; Lee W.-J.; Lin J.-T.
臺大學術典藏 2020-11-27T03:28:38Z Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen–Negative Patients Hsu Y.-C.; Mo L.-R.; Chang C.-Y.; Wu M.-S.; Kao J.-H.; Wang W.-L.; Yang T.-H.; Wang C.-S.; Chiang M.-F.; CHIEH-CHANG CHEN; Fang Y.-J.; Hung H.-W.; Wu C.-Y.; Lin J.-T.

Showing items 1-25 of 45  (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page